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urrent challenges to investigator driven research 
The national climate for biomedical research has changed dramatically over 
the past 10-12 years since the last stages of the doubling of the NIH budget 
were completed in 2003. These changes have resulted in significant new challenges to 
the concept of investigator-driven basic research at medical schools and undergraduate 
research campuses across the nation. The biomedical research enterprise, fueled by the 
resources provided to the NIH and other federal research agencies during the growth 
period, was incentivized to recruit an expanding work force to meet the research ob-
jectives of individual investigator research grants. 
 
The growth of individual laborato-
ries and trainee populations was unsus-
tainable over the long term as the federal 
research funds began to diminish. Federal 
funding in real dollars is currently 25% 
below the levels reached in 2003, resulting 
in a hyper-competitiveness for limited re-
sources and an abundance of young in-
vestigators struggling to find research-
based academic positions or the necessary 
funding to launch and sustain a produc-
tive research career1. As grant application 
rates have risen considerably over the 
past 10 years, success rates have tumbled 
from 20-30% at the beginning of this cen-
tury to the current state of 10-13%. Pay-
lines were reduced to the 6th-8th percentile 
for many NIH institutions, with a 3-4 per-
centile bump for early stage investigators 
(see individual NIH institutional data on 
the web). These historically low levels 
have had a depressing impact on the con-
tinued recruitment and retention of bright 
young scientists that are the future of our 
scholarly environments at research insti-
tutions. As a result, new strategies have to 
emerge for building research strengths 
and infrastructure that are interdiscipli-
nary in nature and responsive to the 
changing requirements for successfully 
competing in the current environment. 
Historically, in a medical school set-
ting, basic science departments focused 
on recruiting academic expertise that cen-
tered on human clinical interests in infec-
tious diseases, immunity and human dis-
eases that were associated with either of 
these “subdisciplines”. In most cases, in-
dividual faculty research interests were 
somewhat isolated, giving the depart-
ment as a whole a breadth of perspectives 
that encompassed the scope of medical 
microbiology and immunology expertise. 
The teaching mission was concentrated 
on the one hand to providing a basic un-
derstanding of all aspects of infection and 
immunity, and related human physiolog-
ical consequences, to an information-
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stressed medical student class through di-
dactic lecture and case examples, and on 
the other to training the next generation 
of basic scientists to join the academy and 
continue the more or less siloed discipli-
nary environment. On an undergraduate 
campus, the scope of academic expertise 
to meet student intellectual interests ex-
panded outside the biomedical realm to 
include microbial interactions with ani-
mals and plants, as well as environmental 
and industrial microbiology.  
When a tenure track faculty position 
was vacated or a new position created, the 
recruitment strategy was to replace that 
expertise in a general sense – e.g. bacterial 
or viral pathogenesis, host immunity, etc. 
A search ensued by casting a broad net in 
the designated subdiscipline, hoping to 
catch the best available young scientists in 
that area. Most searches were targeted to 
the Assistant Professor level and most 
candidates were coming out of postdoc-
toral fellowships, with little or no experi-
ence with major grant applications, and 
thus little or no funding to initiate the 
transition to independence. By the time 
the top candidate or two was selected, in-
terviewed and a transition package nego-
tiated, the replacement process could be 
expected to take 6-12 months. That pro-
cess worked well in the sense of infusing 
the faculty with youth, intellectual crea-
tivity and technical rejuvenation. It cre-
ated many opportunities for the pipeline 
of young scientists being trained around 
the country, most supported by individ-
ual or training grants from the NIH. 
Prior to 2003, the recruitment pack-
ages for faculty candidates at the Assis-
tant Professor level were designed to give 
the investigator enough resources to get 
an independent research program off the 
ground and to the point of being compet-
itive for federal grant awards. The stand-
ard calculation was three years of full sal-
ary support and $300-500K to fund equip-
ment, personnel and supplies for the tran-
sition period. This assumed no additional 
specialized high end instrumentation was 
needed or what was needed was already 
in place within the institution. Those esti-
mates were defined by statistical data that 
suggested approximately three years 
from faculty appointment to the first 
awarded federal grant, up from one year 
in 1980 (2). With the first award and sub-
sequent renewal, the institution’s invest-
ment was quickly recovered. I should 
point out that there were also occasional 
targeted searches for investigators at a 
more senior level, with higher levels of in-
vestment required and correspondingly 
higher levels of expectations, including 
that these recruits were expected to bring 
significant grant resources with them 
along with an established and recognized 
research program. In other words, though 
there was a greater upfront investment, 
there was less risk in evaluating the long 
term potential of the recruit to maintain a 
productive research program. 
In the period since the NIH doubling, 
the landscape around biomedical re-
search has changed dramatically, espe-
cially with respect to recruitment of fac-
ulty investigators in the early stages of 
their careers. Young scientists are having 
to spend more time in prefaculty training 
positions because of the decline in open 
faculty positions. According to an NIH 
study, the average age at which PhD re-
cipients are recruited into their first ten-
ure track position is now 37 years and, 
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when you couple this fact with the ever 
diminishing grant funding success rates, 
it now takes an average of 4-5 years in that 
position to win an initial federal grant, if 
at all2. As a result, the initial investment 
by the institution in salary and startup 
must consider additional resources for 
the fourth and fifth years of faculty devel-
opment, resources that are substantially 
at risk. This pushes the packages to 
$700K-$1M for an untested Assistant Pro-
fessor, and higher for established investi-
gators. Furthermore, the extended transi-
tion period for junior faculty runs head-
on into the tenure clocks of many institu-
tions, which are still geared to 5-6 years. If 
the first award occurs near the decision 
year, there are no definitive data to assess 
long term stability for many research pro-
grams.  
What about retention of not only 
those junior faculty with a high likelihood 
of success, but also of the top research fac-
ulty once their research programs have 
become firmly established and ade-
quately funded? Given the fact, as will be 
discussed in the sections that follow, that 
many institutions, including MU, have 
begun to emphasize targeted recruitment 
of faculty into strategic areas of research 
strength and who have a strong federal 
funding record, what investments must 
be made to enhance the probability for 
successful strategic recruitment and re-
ciprocally for keeping the best early stage 
investigators from being poached? In our 
collective discussions here at MU, the so-
lutions revolve around the establishment 
of critical environments – a creative (inno-
vative) and supportive environment, 
which includes technology enhancement, 
to attract the best and brightest, and an ef-
fective mentoring environment to sup-
port and retain our strongest young in-
vestigators.  
1. A creative environment really de-
pends on minimizing barriers to effec-
tive interdisciplinary research interac-
tions, including the development of 
research and technology centers that 
promote such interactions. The era of 
individual investigators working 
with one or two students in an iso-
lated laboratory is approaching ex-
tinction as faculty (and funding agen-
cies) realize the effectiveness and im-
pact of scientific collaboration to bring 
diverse intellectual and technical skill 
sets together to address significant 
scientific questions.  
2. A supportive environment empha-
sizes recognition, as well as rewards 
(including competitive salary struc-
tures and incentives), for achieving 
important benchmarks in scientific 
discovery that bring visibility to the 
institution, not only in scientific cita-
tion, but in research funding as well. 
A supportive environment also recog-
nizes the critical importance of invest-
ments in research infrastructure, espe-
cially with respect to cutting edge in-
strumentation and the technological 
support needed to transfer these tech-
nologies to individual/collaborative 
research programs. 
3. An effective mentoring environment 
is essential in the early and sustained 
success of the next generation of aca-
demic scientists. A strong mentorship 
program will connect faculty early in 
their careers with established investi-
gators who are experienced, not only 
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in the relevant scientific disciplines 
and technologies and can provide 
peer review for grant applications and 
manuscripts, but as well in navigating 
the ever more difficult regulatory en-
vironment and government reporting 
on such issues as animal welfare, radi-
ation safety and human subjects re-
search. Institutionally, resources must 
be directed toward career develop-
ment and effective teaching modali-
ties. Faculty mentoring should also in-
clude an ongoing evaluation of how 
their respective research interests con-
nect to advertised research priorities 
at federal agencies like the NIH. 
Departmental strategies for targeted 
recruitment and integration into an in-
terdisciplinary framework 
We are now in a period where federal 
funding of basic biomedical research is 
not allocated in a way that affords the pre-
dictability and stability for growing re-
search programs as it once did. To be 
more effective in the environment of in-
creasing competitiveness for these critical 
but limited resources and to be more re-
sponsive to developing research initia-
tives from institutions like the NIH, pub-
lic research institutions must be more cre-
ative and realistic in their approaches to 
investing in research scientists who fit 
well with interdisciplinary programmatic 
strengths. They must use these strengths 
as well to explore new funding opportu-
nities in both the public and private sec-
tors. This implies strategically targeted re-
cruitments that fill important needs in 
currently strong research areas at the ex-
pense of the previously favored broad 
spectrum approach, despite the latter’s 
evidence of success in clearly identifiable 
examples. Recruitments and retentions 
for that matter must be evaluated with in-
tegration in mind, integration with exist-
ing research strengths and integration 
with changing funding agency strategic 
plans (e.g. see NIAID Strategic Plan 2013; 
http://www.niaid.nih.gov/about/who-
WeAre/planningPriorities/Docu-
ments/NIAIDStrategicPlan2013.pdf). 
There are clear examples from recent NIH 
initiatives in the Human Genome Project, 
the BRAIN Initiative and the Human Mi-
crobiome Project, all of which allocated 
impressive research resources toward es-
tablishing basic research foundations that 
will underpin much of the “translational” 
research efforts for the next decade or so. 
These research initiatives, and the 
subsequent applicable biology, are in-
creasingly dependent on an interdiscipli-
nary team approach. It is imperative to 
build collaborative research strengths in 
genomics and metagenomics, bioinfor-
matics, comparative animal models, cel-
lular and structural biology, and drug de-
sign and development to be able to effec-
tively compete for resources under these 
strategic initiatives. In parallel, there are 
changes in the expectations from the 
funding agencies for team-based research 
approaches, and thus there must be 
changes in how public research institu-
tions respond.  
1. Multi-investigator R01-type grants 
are gaining traction and increasing 
support because they bring together 
diverse research talents to address a 
research problem from a variety of 
technical perspectives. These grants 
are less expensive than the previously 
popular Program Project grant be-
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cause they direct all the funding re-
sources to the science and eliminate 
administrative structures that are not 
necessary to accomplish the ultimate 
objectives. There are no institutional 
requirements that the multi-investiga-
tor team reside on the same campus; 
however, recruitment can be influ-
enced by the increased likelihood of 
such proposals being developed 
when recruitment is targeted to re-
search interactions. 
2. Teamwork and complementary skill 
sets may be needed to overcome risk-
averse scientific review panels which 
dominate current review processes. 
Many individual investigator grants 
can be (and are) criticized because of 
the limited expertise/experience of the 
investigator. Strategic team building 
eliminates this as a legitimate scien-
tific criticism in many cases. 
3. The general strategy of building inter-
disciplinary research teams that seek 
funding and publish findings to-
gether also requires that universities 
reevaluate current promotion and 
tenure policies. At present, there are 
significant pressures on junior faculty 
for “independent research” for posi-
tive tenure and promotion decisions. 
Within the productive interdiscipli-
nary team, however, individual con-
tributions are relevant to the success 
of the whole and can be evaluated for 
their respective merit.  
4. As faculty become more entrepre-
neurial and seek new avenues for re-
search funding from the private sec-
tor, these relationships should also be 
evaluated and recognized for their 
contributions to the academic pursuit 
of scientific discovery and should also 
be identified in faculty promotion and 
tenure documentation. 
5. Whether in the academic setting of a 
university or medical school (e.g. 
basic/clinical integration) or in a uni-
versity/industry partnership, there is 
an increasing emphasis on “transla-
tional applications”.  
For an academic research department 
to be effective in the research environ-
ment that is likely to dominate the na-
tional science agenda for the foreseeable 
future, there must be a continuous assess-
ment of departmental research strengths 
relative to campus and regional intellec-
tual and technical resources and NIH re-
search priorities. How well do investiga-
tor research strengths integrate with cam-
pus and regional research opportunities 
and match with changing NIH strategic 
plans? From such assessments, a strategic 
recruitment plan should emerge that 
makes these integrations more effective, 
resulting in enhancement of opportuni-
ties to be competitive for multi-investiga-
tor research programs and a greater turn-
around time for institutional return on in-
vestment. 
Using the Department of Molecular 
Microbiology and Immunology at the MU 
School of Medicine as an example, the 
analysis of our research strengths with 
those of the campus as a whole and the 
available technical resources enable a 
more effective strategic plan for targeted 
recruitment of new faculty talent to de-
velop. One advantage is that MU is a com-
prehensive campus, with multiple col-
leges engaging in life sciences research. 
As we look around campus (concentrat-
ing on areas likely to synergize with 
 91 
 
MMI), easily identifiable strengths in-
clude: 
• Comparative medicine – with the Col-
leges of Medicine and Veterinary 
Medicine, the Division of Animal Sci-
ences in Agriculture and three NIH-
funded Animal Resource Centers 
(mutant mouse, rat and swine), MU 
has a strong cadre of research exper-
tise in the genetic manipulation of an-
imal models for both agricultural and 
medical research. 
• Plant and animal genomics – MU has 
long been a national leader in plant 
genetics and genomics and continues 
to invest in partnerships that enhance 
this strength (including the recent 
agreement with the Danforth Plant 
Science Center in St. Louis to strategi-
cally recruit four new investigators to 
build greater integration between the 
two campuses). MU has made semi-
nal contributions to both the bovine 
and swine genomic projects and is a 
national leader in genetic manipula-
tion of swine as animal models for hu-
man disease. 
• Biological engineering and nanotech-
nology – Bioengineering faculty re-
search strengths focus on nanostruc-
tured biocomposites for tissue inte-
gration, development of novel sens-
ing mechanisms and platforms, single 
molecule technologies for disease bi-
omarker detection and improved 
DNA sequencing, epigenetics and 
proteome detections, and nanoparti-
cle development for targeted tissue 
delivery of molecular reagents and 
vaccines. 
• Structural biology – Significant intel-
lectual technical resources for crystal-
lography and x-ray diffraction, NMR 
spectroscopy and mass spectrometry 
provide critical opportunities for de-
termining protein structures, protein-
protein and protein-lipid interactions, 
and macromolecular identification. 
The MMI departmental research 
strengths are centered on: 
• Viral pathogenesis, including capsid 
and polymerase structure and func-
tion, antiviral therapies (small mole-
cules and RNA aptamers), viral-cellu-
lar interactions in viral entry, replica-
tion and assembly and the use of viral 
vectors in gene therapy for human ge-
netic disorders like Duchenne muscu-
lar dystrophy and spinal muscular at-
rophy; 
• Immune response to viral and bacte-
rial pathogens and autoimmune dis-
eases including diabetes, multiple 
sclerosis, asthma, inflammatory 
bowel diseases; 
• Bacterial genetics and pathogenesis, 
including membrane biology, adhe-
sion of host cell receptors, invasion 
structures and functions, bacterial ge-
netics and genetic manipulation, met-
agenomics of the microbiome, bacte-
rial toxins and their molecular interac-
tions with mammalian cellular targets 
and genetic diversity generating ele-
ments. 
With these two comparative lists in 
mind, we would focus the development 
of a recruitment strategic plan to take ad-
vantage of the likely connections between 
departmental strengths, those of our com-
prehensive research campus and devel-
oping NIH research initiatives (along 
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with entrepreneurial opportunities in the 
private sector). One objective of such inte-
grated recruitment would be to create in-
terdisciplinary centers of excellence that 
amplify the potential of any individual or 
small group of investigators to compete 
effectively for public or private sector re-
sources. Integrated within this plan 
would also be an increasing emphasis on 
“translational partnerships” in the clinical 
sciences (human and veterinary medi-
cine), the agricultural sciences, bio- and 
chemical engineering, and of course eco-
nomic development. For example: 
• In the area of virology and viral path-
ogenesis, our nationally recognized 
strength is in HIV/AIDS, hepatitis C 
and emerging viruses like Ebola and 
SARS/MERS. Strategic recruitment of 
investigators with interests in viral 
structures as targets for drug develop-
ment, viral vaccine development and 
delivery and viral diagnostics will 
open up significant new opportunities 
not only for federal research pro-
grams, but for global infectious dis-
ease initiatives and pharmaceutical 
industry partnerships. 
• In the area of microbial pathogenesis 
and the microbiome, we have devel-
oped a technology pipeline to interro-
gate the microbial metagenome 
within any population niche (clinical 
or environmental). Collaborations are 
rapidly developing with animal scien-
tists interested in the ruminant micro-
biome and its relationship to animal 
health and food production, plant sci-
entists interested in the plant rhizo-
sphere and it role in plant nutrition 
and disease, human nutritionists in-
terested in dietary caloric extraction 
and health/obesity, and clinical scien-
tists interested in the relationships be-
tween the human microbiome (espe-
cially gut and vaginal) and human 
health/diseases. Given that NIH has 
already invested heavily in the foun-
dation for studies in the human mi-
crobiome and has recently announced 
major new initiatives in these areas 
(included in Priority 3 of the recent 
NIAID Strategic Plan referenced 
above), strategic recruitment of meta-
genomics and informatics expertise 
that can collaborate with ongoing 
campus program development repre-
sents an exciting new opportunity. 
• In the area of immunology, NIAID 
continues to emphasize basic innate 
and acquired immune mechanisms 
and the complex interactions between 
microbial pathogens and the immune 
system to develop and test therapeu-
tic and vaccine strategies. In addition, 
new emphasis is being placed on de-
velopment of the innate and acquired 
immune systems in relationship with 
the gut microbiome. Departmental re-
search strengths in T and B cell devel-
opment, immune memory and innate 
defenses and autoimmune diseases 
provide a foundation for targeted re-
cruitment (in cooperation with Veter-
inary and Animal Sciences and Bioen-
gineering) in the function of a healthy 
immune system, vaccine develop-
ment and robust protection against 
bacterial and viral pathogens, and the 
underlying causes of diseases like di-
abetes, allergies and inflammation.  
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Technology infrastructure and de-
velopment investments 
Maintaining a cutting-edge technol-
ogy infrastructure is essential to creating 
an institutional environment where our 
investigators can effectively and produc-
tively meet their ongoing and developing 
research objectives and within which we 
can recruit strategic new talent. On many 
of our campuses, there are unique re-
sources (like the MU Research Reactor) 
that bring national visibility to the institu-
tion and are a strong marketing tool for 
recruiting the top scientific talent. How-
ever, there is significant (and continually 
expanding) expense associated with high-
end instrumentation and the technical ex-
pertise needed for continued develop-
ment of the technologies and communica-
tion of their potential to the research com-
munities on our campuses. As a result, 
public institutions, in this period of di-
minishing state and federal revenue 
sources to support the necessary techno-
logical infrastructure, will benefit from in-
novative ideas to centralize (and not du-
plicate) the needed technologies and to 
communicate their availabilities to the lo-
cal and regional scientific communities. 
This concept has been critically important 
on the MU campus and has great poten-
tial within the Missouri-Kansas region in 
general. I will briefly discuss how the MU 
campus is currently implementing a core 
facility infrastructure and the develop-
ment of recent initiatives to communicate 
these technology capabilities to other re-
gional institutions. 
The real thrust to identify and consol-
idate our institutional technology re-
sources began in the late 1980’s with the 
development and implementation of a 
“Core Facilities” concept. For example, 
MU had 3-4 electron microscopes scat-
tered among its various colleges and not 
enough local resources to maintain and 
operate them effectively as separate in-
struments. Consolidating them into an 
Electron Microscopy Core streamlined 
their operational requirements and made 
it possible to recruit top technical talent to 
provide the technical expertise that cam-
pus investigators needed to justify spe-
cific experimental strategies in their grant 
applications. Similar consolidations and 
investments have been made since that 
time to centralize instrumentation and ex-
pertise in NMR spectroscopy, mass spec-
trometry (for both macromolecules and 
small molecules), confocal microscopy, 
flow cytometry, DNA and RNA genomics 
and transcriptomics, bioinformatics, 
structural biology and x-ray diffraction, 
and transgenic animal production. The 
result is a robust core facility system that 
is administered through the campus Of-
fice of Research (www.research.mis-
souri.edu/division/cores). It is also im-
portant to emphasize that other technol-
ogy facilities on our regional campuses 
are less centralized but nonetheless avail-
able for collaboration. On the MU cam-
pus, these include the VA Biomolecular 
Imaging Core (small animal whole body 
imaging), the Brain Imaging Core (with a 
3T MRI), the Plant Transformation Core, 
the International Institute for Nano and 
Molecular Medicine, the Nanofabrication 
and Material Sciences Core and of course 
the MU Research Reactor. 
The advantages of centralizing such 
technologies of course are easy to enu-
merate. They provide the cutting-edge 
technologies and state-of-the-art high end 
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(and very expensive) instrumentation 
needed to produce competitive research 
proposals. They provide technical exper-
tise on site – as investigators integrate the 
newest and most sensitive or quantitative 
technologies into their research program, 
they rely on the technical support and 
consultations with the core facility tech-
nical staff. And as importantly, they offer 
the services at competitive rates because 
they can spread the costs over many pro-
jects and investigators. Implementation of 
many of these technologies on a depart-
mental or even college level would be cost 
prohibitive. 
There are considerable challenges as 
well, even with a robust core facility sys-
tem. (i) High end technologies are expen-
sive from both the equipment and tech-
nical personnel perspectives. Spreading 
the fixed costs out to keep fee structures 
low and affordable requires an adequate 
user base. At any one institution, there 
may be a limited number of specific tech-
nology users (though it is absolutely es-
sential to their research progress). Ac-
cording to national core facility bench-
marking studies provided each year by 
iLab Solutions, the current rate of institu-
tional subsidization of such technologies 
is 30%. (ii) State-of-the-art instrumenta-
tion is evolving at a rate faster that its de-
preciation, making it continuously more 
difficult to keep pace. This is clearly ap-
parent with genomics technologies where 
implementation of the latest instrument 
(at $500-700K per instrument) is soon out-
dated by the introduction of a new tech-
nology. (iii) And finally, the critical tech-
nical expertise on site is increasingly dif-
ficult and more expensive to recruit and 
retain. Without this expertise, the technol-
ogies are available to only a select few 
highly trained scientists. 
With the increasing costs to individ-
ual institutions of providing core techno-
logical resources, especially when the 
user base for any one expensive technol-
ogy may be limited at a given institution, 
there is merit in marketing these technol-
ogies regionally. Such a strategy would 
benefit the institution supporting the 
technology by spreading costs over a 
stronger user base and would open new 
opportunities for collaboration, and it 
would also benefit the regional institu-
tions by preventing the unnecessary du-
plication of expensive technologies. There 
is a strong interest from the Missouri-
Kansas region to develop strategic part-
nerships that encourage and support 
technology sharing in this way. A consor-
tium of institutions, including MU, KU, 
KU Medical Center, Kansas State, and the 
Kansas City Area Life Sciences Institute, 
with its academic, health and corporate 
membership, have recently undertaken a 
project to bring the regional technical and 
intellectual resources together using a 
web-based communications and market-
ing tool to illustrate the regional capabili-
ties and academic expertise and provide 
its representative scientific communities a 
source of information for identifying 
needed resources. This tool, to be known 
as the BioInnovation Research Exchange 
(BRIX) is being developed in partnership 
with a California-based company called 
Assay Depot, founded by MU graduate 
Kevin Lustig. The tool should be ready for 
implementation within calendar year 
2015. 
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